Plain-English translation of NCT04157569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at a special blood test that can detect tiny pieces of cancer DNA left in your bloodstream after you receive chemotherapy for acute leukemia. By measuring these cancer markers over time, doctors hope to better understand whether your treatment is working and to catch any problems early. This information could help guide your care and improve outcomes for older adults being treated for this disease.
Currently, doctors don't have a reliable way to quickly tell if chemotherapy is truly eliminating leukemia cells in older adults. This study aims to fill that gap by testing whether this special blood test can predict treatment success and help doctors make faster, better decisions about your care.
You likely qualify if…
You likely don't qualify if…
You would have blood samples collected as part of your regular chemotherapy care. Using a specialized technique, researchers will measure cancer DNA in your blood to see how your body is responding to treatment. The exact schedule of visits and blood draws would be coordinated with your ongoing cancer treatment plan.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
~200 participants
Started
November 2019
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
60 Years – 100 Years
Last updated on clinicaltrials.gov in February 2020.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Liren Qian, MD
Navy General Hospital, Beijing
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.